Bradykinin inhibits hepatic gluconeogenesis in obese mice (Q38322918)

2 September 2017

title

Bradykinin inhibits hepatic gluconeogenesis in obese mice (English)

1 reference

2 September 2017

0 references

1 reference

hepatic gluconeogenesis

1 reference

14

1 reference

2 September 2017

Sandro Soares Almeida

object named as

Sandro Soares Almeida

6

0 references

Ronaldo C. Araujo

object named as

Ronaldo Carvalho Araujo

16

0 references

Marcelo A Mori

object named as

Marcelo Mori

11

0 references

author name string

Carlos Castilho Barros

1

1 reference

2 September 2017

Carlos Castilho Barros

2

1 reference

2 September 2017

Anderson Haro

3

1 reference

2 September 2017

Fernanda Jaqueline Russo

4

1 reference

2 September 2017

Ines Schadock

5

1 reference

2 September 2017

Felipe Castellani Reis

7

1 reference

2 September 2017

Milton Rocha Moraes

8

1 reference

2 September 2017

Andre Haidar

9

1 reference

2 September 2017

Aparecida Emiko Hirata

10

1 reference

2 September 2017

Reury Frank Pereira Bacurau

12

1 reference

2 September 2017

Martin Würtele

13

1 reference

2 September 2017

Joao Bosco Pesquero

15

1 reference

2 September 2017

publication date

6 August 2012

1 reference

2 September 2017

published in

Laboratory Investigation

1 reference

2 September 2017

volume

92

1 reference

2 September 2017

issue

10

1 reference

2 September 2017

page(s)

1419-1427

1 reference

describes a project that uses

2 September 2017

real-time polymerase chain reaction

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/labinvest.2012.105

0 references

cites work

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Type 2 diabetes and obesity: genomics and the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Role of the B(2) receptor of bradykinin in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Involvement of protein kinase A in nitric oxide stimulating effect on a BK(Ca) channel of human dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Efficient method for obtaining Lep(ob)/Lep(ob)-derived animal models using adipose tissue transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

The physiology of obese-hyperglycemic mice [ob/ob mice].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Adipose tissue distribution is different in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Hepatic glucose metabolism in humans--its role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Forkhead box transcription factor O1 inhibits cholesterol 7alpha-hydroxylase in human hepatocytes and in high fat diet-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Structure/function relationships underlying regulation of FOXO transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Interleukin-10 is a protective factor against diet-induced insulin resistance in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Novel concepts in insulin regulation of hepatic gluconeogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

Bradykinin increases intracellular free Ca2+ concentration and promotes insulin secretion in the clonal beta-cell line, HIT-T15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

The effect of bradykinin on secretion of insulin, glucagon, and somatostatin from the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

The impact of obesity on diabetes mellitus and the role of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Blockade of kinin B(1) receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Swimming training exacerbates pathological cardiac hypertrophy in kinin B2 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Involvement of bradykinin and nitric oxide in leptin-mediated glucose uptake in skeletal muscle.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin-converting enzyme and other peptidases.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Effect of captopril, losartan, and bradykinin on early steps of insulin action

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Participation of the liver gluconeogenesis in the glibenclamide-induced hypoglycaemia in rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Development of the obese-hyperglycaemic syndrome in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Suppressor of MEK null (SMEK)/protein phosphatase 4 catalytic subunit (PP4C) is a key regulator of hepatic gluconeogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

PGC-1alpha coactivates estrogen-related receptor-alpha to induce the expression of glucokinase

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Early hepatic insulin resistance in mice: a metabolomics analysis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

Bradykinin enhances membrane electrical activity of pancreatic beta cells in the presence of low glucose concentrations

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.105

7 January 2021

10.1038/LABINVEST.2012.105

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1010528346

0 references

1 reference